Impact of a History of COVID-19 Infection on Postoperative Outcomes for Free Flap Patients.
Abstract
This study examines the impact of a history of coronavirus disease 2019 (COVID-19) infection on patients' outcomes after microvascular free flap surgery and to examine the recommendations on when to perform microvascular surgery after a COVID-19 infection. A retrospective chart review using the TriNetX database was completed on March 5, 2023. Two cohorts were created: (1) patients who had a positive COVID-19 diagnosis within 1 year before microvascular free flap surgery, and (2) patients with no history of COVID-19 who underwent free flap surgery. Current Procedural Terminology codes were used to identify procedures and International Classification of Diseases-10 codes were used to identify outcomes. There was a total of 31,505 patients who underwent microvascular free flap surgery, 500 of whom had a diagnosis of COVID-19 within 1 year of free flap surgery and 31,005 without history of COVID-19. There was increased risk of sepsis, surgical site infection (SSI), generalized infection, gangrene, dehiscence, hematoma, seroma, intensive care unit admission, and death in patients who underwent free flap surgery within a year of COVID-19 infection. After propensity score matching, there were 498 patients in both groups. Increased risk remained for SSI and gangrene in patients with a history of COVID-19 after matching. When comparing surgical timing between 0 to 2 months after COVID-19 infection and 2 to 12 months after COVID-19 infection, there were no significant differences between groups. After propensity score matching, patients with a history of COVID-19 infection were at increased risk for SSI and gangrene. However, many flap surgeries cannot be delayed. This study may help counsel patients regarding the possible complications after surgery and provide a heightened awareness in the surgical team of a possible increase in infectious complications in this population. Additional studies should investigate optimal timing of free flap surgery after COVID-19 infection and ways to mitigate the risk of infectious complications.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 합병증 | infection
|
감염 | dict | 9 | |
| 시술 | free flap
|
피판재건술 | dict | 8 | |
| 시술 | microvascular
|
미세수술 | dict | 4 | |
| 합병증 | ssi
|
감염 | dict | 3 | |
| 시술 | flap
|
피판재건술 | dict | 1 | |
| 합병증 | Flap Patients
|
scispacy | 1 | ||
| 합병증 | hematoma
|
혈종 | dict | 1 | |
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | surgical site infection
|
감염 | dict | 1 | |
| 합병증 | dehiscence
|
상처열개 | dict | 1 | |
| 약물 | COVID-19
→ coronavirus disease 2019
|
scispacy | 1 | ||
| 질환 | coronavirus disease 2019
|
C5203670
COVID19 (disease)
|
scispacy | 1 | |
| 질환 | sepsis
|
C0036690
Septicemia
|
scispacy | 1 | |
| 질환 | gangrene
|
C0017086
Gangrene
|
scispacy | 1 | |
| 질환 | death
|
C0011065
Cessation of life
|
scispacy | 1 | |
| 질환 | COVID-19 infection
|
C5203670
COVID19 (disease)
|
scispacy | 1 | |
| 질환 | infectious
|
C0009450
Communicable Diseases
|
scispacy | 1 | |
| 기타 | coronavirus disease 2019
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Breast plastic surgery in perimenopausal and postmenopausal women: Menopause-informed counseling on screening, safety, and long-term breast health.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Free flap reconstruction of a cast-related pressure ulcer in a pediatric patient with spinal muscular atrophy.